Sandler Capital Management’s Edwards Lifesciences EW Stock Holding History

Sandler Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-98,760	Closed	-$4.79M	–	126
2018 Q2	$4.79M	Sell	98,760 -168,540	-63%	-$7.87M	0.4%	72
2018 Q1	$12.4M	Buy	+267,300	New	+$11.6M	1.52%	19
2017 Q3	–	Sell	-100,500	Closed	-$3.96M	–	126
2017 Q2	$3.96M	Buy	+100,500	New	+$3.67M	0.43%	84
2015 Q2	–	Sell	-168,000	Closed	-$3.99M	–	192
2015 Q1	$3.99M	Buy	+168,000	New	+$3.77M	0.25%	148

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sandler Capital Management's EW Position: Q3 2018 in Review

Sandler Capital Management sold out of Edwards Lifesciences (EW) in Q3 2018, closing a stake of 98,760 shares — an estimated $4.79M sold.

Sandler Capital Management first reported a position in EW in Q1 2015 and held it in 4 quarters. The position peaked at $12.4M in Q1 2018. 852 funds tracked by Wall St. Rank hold EW as of Q3 2018.

Sandler Capital Management reported no remaining Edwards Lifesciences position as of Q3 2018 after selling out during the quarter.
Sandler Capital Management sold 98,760 Edwards Lifesciences shares in Q3 2018, an estimated $4.79M.
Sandler Capital Management first reported a position in Edwards Lifesciences in Q1 2015 and held it in 4 quarters.
Sandler Capital Management's Edwards Lifesciences position peaked at $12.4M in Q1 2018.
852 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2018.

Based on Sandler Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.